Benefit Systems SA BENEFIT SYSTEM.../ PLBNFTS00018 /
17/05/2024 17:47:01 | Chg. - | Volume | Bid06:00:04 | Ask06:00:04 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
2,728.6PLN | - | 10 Turnover: 27,285.7 |
-Bid Size: - | -Ask Size: - | 8.18 bill.PLN | - | 18.62 |
GlobeNewswire
14/06
INVESTOR ALERT: Edelson Lechtzin LLP Urges Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) Shareholders...
GlobeNewswire
14/06
INVESTOR ALERT: Edelson Lechtzin LLP Urges Hertz Global Holdings, Inc. (NASDAQ: HTZ) Shareholders to...
GlobeNewswire
14/06
Roanoke Gas Company Celebrates Historic Milestone: New Interstate Natural Gas Pipeline Mountain Vall...
GlobeNewswire
14/06
Weekly Report (June 7-13, 2024) Second Tranche of Stellantis 2024 Share Buyback Program
GlobeNewswire
14/06
Empowering Financial Independence: NAST & ABLE today Launch Innovative Savings Resources
GlobeNewswire
14/06
Chiesi Global Rare Diseases Showcases Ongoing Commitment to Multiple Rare Diseases Communities at EN...
GlobeNewswire
14/06
SEER RECEIVES CONTRACT FROM BIOCHAR NOW FOR THE MANUFACTURING OF KILNS AND INTENDS TO OPEN A JV TEXA...
GlobeNewswire
14/06
Document Mining and Analytics Platforms Report Recognizes IDOL™, Supplied to the U.S. Government by ...
GlobeNewswire
14/06
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Agains...
GlobeNewswire
14/06
CryptoHeap Introduces Exclusive Crypto Staking Plans for Enhanced Investor Rewards
GlobeNewswire
14/06
Brians Auto Repair Celebrate Sponsorship Award from Florida’s Coastal Conservation Association
GlobeNewswire
14/06
Brookfield Business Partners L.P. 2024 Second Quarter Conference Call and Webcast for Investors and ...
GlobeNewswire
14/06
Shattuck Labs Announces Updated Positive Interim Data from the Phase 1B Dose Expansion Clinical Tria...
GlobeNewswire
14/06
Early Signals by WOO X: BTC Faces Downward Trend While TON Ecosystem Reaches New Highs with Surging ...
GlobeNewswire
14/06
Editas Medicine Reports New Safety and Efficacy Data from the RUBY Trial of Reni-cel in 18 Patients ...
GlobeNewswire
14/06
Editas Medicine Announces New Safety and Efficacy Data from the EdiTHAL Trial of Reni-cel in 7 Patie...
GlobeNewswire
14/06
Cabaletta Bio Reports Positive Initial Clinical Data from Phase 1/2 RESET-Myositis™ and RESET-SLE™ T...
GlobeNewswire
14/06
Rezolute Announces Pricing of Public Offering of $60 Million of Common Stock and Pre-Funded Warrants